Haim Danenberg, MD

Original Contribution

Efficacy and Safety of Novel NovaCross Microcatheter for Chronic Total Occlusions: First-in-Human Study

02/29/2016

Abid R. Assali , MD;

Ran Kornowski , MD;

Dariusz Dudek , MD, PhD, FESC;

Colm G. Hanratty , MD;

Leszek Bryniarski , MD, PhD, FESC;

Simon J. Walsh , MD;

Haim Danenberg , MD;

Chaim Lotan , MD;

Piotr Wilkołek , MD, PhD;

The aim of this first-in-human (FIH) study was to evaluate the efficacy and safety of the novel NovaCross microcatheter system in eligible consecutive patients with chronic total occlusion (CTO).

The aim of this first-in-human...

02/29/2016

Journal of Invasive Cardiology

Original Contribution

Generational Differences in Outcomes of Self-Expanding Valves for Transcatheter Aortic Valve Replacement

04/01/2022

Shmuel Banai , MD;

Haim Danenberg , MD;

Aviram Hochstadt , MD;

Itamar Loewenstein , MD;

David Zahler , MD;

Ariel Finkelstein , MD;

Hana Vaknin-Assa , MD;

Yan Topilsky , MD;

Katia Orvin , MD;

Maayan Konigstein , MD;

Shmuel Bazan , MD;

David Planner , MD;

Arie Steinvil , MD;

Amir Halkin , MD;

Abid R. Assali , MD;

Victor Guetta , MD;

Ran Kornowski , MD;

Israel M. Barbash , MD;

Amit Segev , MD;

The Medtronic Evolut Pro valve (EPV) is a new-generation self-expanding valve (SEV), particularly designed to reduce paravalvular leak (PVL) rates in transcatheter aortic valve replacement (TAVR). We aimed to compare the safety and efficacy...

The Medtronic Evolut Pro valve...

04/01/2022

Journal of Invasive Cardiology